News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Phyton Biotech, Inc. Receives CEP for Paclitaxel API Produced by Plant Cell Fermentation


7/17/2012 9:47:13 AM

VANCOUVER, British Columbia--(BUSINESS WIRE)--Phyton Biotech, a global supplier of high quality paclitaxel and docetaxel API, has been granted a Certificate of suitability to European Pharmacopeia (CEP) by the European Directorate for the Quality of Medicines and HealthCare (EDQM) for its paclitaxel active pharmaceutical ingredient (API) produced from plant cell fermentation. Phyton’s CEP application was filed in October 2011.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES